表紙:アレルギー治療薬の世界市場- 世界の産業規模、シェア、動向、機会、予測、2017年~2027年、タイプ別、治療法別、投与経路別、流通チャネル別、地域別分析
市場調査レポート
商品コード
1289640

アレルギー治療薬の世界市場- 世界の産業規模、シェア、動向、機会、予測、2017年~2027年、タイプ別、治療法別、投与経路別、流通チャネル別、地域別分析

Global Allergy Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Type, By Treatment, By Route of Administration, By Distribution channel, By Region

出版日: | 発行: TechSci Research | ページ情報: 英文 115 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

アレルギー治療薬の世界市場- 世界の産業規模、シェア、動向、機会、予測、2017年~2027年、タイプ別、治療法別、投与経路別、流通チャネル別、地域別分析
出版日: 2023年06月01日
発行: TechSci Research
ページ情報: 英文 115 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

世界のアレルギー治療薬市場は、予測期間である2023-2027年に安定したCAGRの成長を遂げると予測されています。

これは、世界中の人々の間で、さまざまな種類のアレルギーの有病率が高まっていることに起因しています。Food Allergy Research &Educationが2020年に発表した報告書によると、米国では約3200万人が食物アレルギーを持っていると推定されています。さらに、市販薬の使用の増加やセルフメディケーションの人気の高まりは、世界のアレルギー治療薬市場の成長に有利な機会を生み出すとさらに期待されています。さらに、さまざまなアレルギーの治療に対する免疫療法の人気の高まりは、市場の成長をさらに後押しすると期待されています。さらに、世界中で老年人口が増加していることから、さまざまなアレルギー治療薬に対する需要が増加すると予想されます。高齢者は免疫力が低下し、さまざまな種類のアレルギーにかかりやすくなるため、さまざまなアレルギーを治療するためのさまざまな治療オプションに対する需要が高まると考えられます。

汚染レベルの上昇

屋内外の汚染の増加は、喘息や気道のさまざまなアレルギー疾患の有病率の上昇につながっています。2019年には、米国の約7.8%の人口が喘息に罹患しています。このことが、2027年までの市場成長に拍車をかけると予想されます。さらに、大気汚染は、頭痛、鼻の詰まりや鼻水、目のかゆみや涙、睡眠障害などのアレルギー性鼻炎の症状を悪化させることがあります。また、屋内外の空気中に含まれるさまざまな汚染物質の存在により、さまざまな目のアレルギーが引き起こされる可能性があることが研究で示唆されています。このため、公害に起因するアレルギーに特化した治療法の需要が高まると予想されます。

アレルギー治療薬のための免疫療法の開発

アレルギー治療薬市場を革新する主な動向のひとつに、さまざまなタイプの免疫療法の発展があります。世界中のさまざまなバイオテクノロジー企業や製薬会社、学術研究機関が、さまざまなアレルギーを治療するための免疫療法を開発するための研究開発に投資しています。例えば、Aimmune Therapeutics, Inc.は、ピーナッツアレルギーの治療を目的とした生物学的免疫療法薬AR101を開発中です。clinicaltrials.govによると、2022年9月現在、世界中で約364のアレルギー免疫療法試験が異なる開発フェーズで実施されています。このことは、世界のアレルギー治療薬市場の成長に有利な機会をもたらすと期待されています。

利用可能なカスタマイズ

TechSci Researchは、与えられた市場データをもとに、企業の特定のニーズに応じてカスタマイズを提供します。本レポートでは、以下のカスタマイズが可能です:

企業情報

  • 追加市場プレイヤーの詳細分析とプロファイリング(最大5社)。

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 アレルギー治療薬の世界市場に対するCOVID-19の影響

第5章 顧客の声

第6章 アレルギー治療薬の世界市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • タイプ別(眼アレルギー、食物アレルギー、皮膚アレルギー、喘息、鼻炎、その他)
    • 治療法別(抗アレルギー薬、免疫療法)
    • 投与経路別(経口剤、吸入剤、鼻腔内投与、その他)
    • 販売チャネル別(病院薬局、小売薬局、オンライン薬局)
    • 地域別
    • 企業別(2021年)
  • 市場マップ

第7章 北米のアレルギー治療薬市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • タイプ別
    • 治療薬別
    • 投与経路別
    • 販売チャネル別
    • 国別
  • 北米:国別分析
    • 米国
    • カナダ
    • メキシコ

第8章 欧州のアレルギー治療薬市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • タイプ別
    • 治療薬別
    • 投与経路別
    • 販売チャネル別
    • 国別
  • 欧州国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第9章 アジア太平洋地域のアレルギー治療薬市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • タイプ別
    • 治療薬別
    • 投与経路別
    • 販売チャネル別
    • 国別
  • アジア太平洋地域の国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第10章 南米のアレルギー治療薬市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • タイプ別
    • 治療薬別
    • 投与経路別
    • 販売チャネル別
    • 国別
  • 南米:国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第11章 中東・アフリカのアレルギー治療薬市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • タイプ別
    • 治療薬別
    • 投与経路別
    • 販売チャネル別
    • 国別
  • MEA:国別分析
    • 南アフリカ
    • サウジアラビア
    • UAE

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場の動向と開拓

第14章 競合情勢

  • Johnson & Johnson
  • Sanofi SA
  • GlaxoSmithKline plc.
  • F. Hoffmann-La Roche AG
  • Leti Pharma GmbH
  • AbbVie Inc.
  • Alembic Pharmaceuticals Limited
  • Bausch Health Companies Inc.
  • Novartis AG
  • ALK-Abello AS

第15章 戦略的な推奨事項

目次
Product Code: 13036

The global allergy treatment market is anticipated to witness a growth of steady CAGR in the forecast period, 2023-2027. This can be ascribed to the growing prevalence of different kinds of allergies among populations across the globe. According to a report published by Food Allergy Research & Education in 2020, estimated that around 32 million residents in the United States have food allergies. Additionally, the growing use of over-the-counter medications and the increasing popularity of self-medication is further expected to create lucrative opportunities for the growth of global allergy treatment market. Besides, the growing popularity of immunotherapy for the treatment of different allergies is further expected to support market growth. Furthermore, the growing geriatric population across the globe is expected to increase the demand for different allergy treatments. The elderly population has a weaker immune system and is more susceptible to different kinds of allergies, thereby increasing the demand for different treatment options for the treatment of various allergies.

Rising Pollution Levels

Increasing indoor and outdoor pollution is leading to an increase in the prevalence of asthma and different allergic disorders of the respiratory tract. In 2019, around 7.8% population in the United States had asthma. This, in turn, is expected to spur the market growth through 2027. Additionally, air pollution can aggravate the symptoms of allergic rhinitides, such as headaches, blocked or runny noses, itchy or watery eyes, and sleep disturbances. Also, studies suggest that different eye allergies can be caused due to presence of different pollutants in indoor and outdoor air. This, in turn, is expected to increase the demand for treatments specific to the allergies caused due to pollution.

Development of Immunotherapies for the Treatment of Allergies

One of the key trends revolutionizing the allergy treatment market is the development of different types of immunotherapies. Various biotechnology & pharmaceutical companies, along with different academic & research institutions across the globe are investing in research & development activities for developing immunotherapies for the treatment of different allergies. For instance, Aimmune Therapeutics, Inc. is developing an investigational biologic immunotherapy drug, AR101, for the treatment of peanut allergy. According, to clinicaltrials.gov, as of September 2022, there are around 364 allergy immunotherapy studies under different phases of development worldwide. This, in turn, is expected to create lucrative opportunities for the growth of global allergy treatment market.

Market Segmentation

Global Allergy Treatment market can be segmented by type, treatment, route of administration, distribution channel, by region. Based on type, the market can be segmented into eye allergy, food allergy, skin allergy, asthma, rhinitis, and others. Based on treatment, the market can be divided into anti-allergy medications and immunotherapy. Based on the route of administration, the market can be differentiated into oral, inhalers, intranasal, and others. Based on distribution channels, the market can be segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. The United States dominates the global allergy treatment market among different countries. This can be ascribed to the growing prevalence of different types of allergies in Americans. A survey conducted in the United States in 2021 stated that around 44% of adults in the United States suffered from pollen allergies, while 15% of the population reported drug allergies.

Market Players

Johnson & Johnson, Sanofi SA, GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Leti Pharma GmbH, AbbVie Inc., Alembic Pharmaceuticals Limited, Bausch Health Companies Inc., Novartis AG, ALK-Abello AS are some of the leading players operating in the Global Allergy Treatment Market.

Report Scope

In this report, Global Allergy Treatment market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Allergy Treatment Market, By Type:

  • Eye Allergy
  • Food Allergy
  • Skin Allergy
  • Asthma
  • Rhinitis
  • Others

Allergy Treatment Market, By Treatment:

  • Anti-Allergy Medications
  • Immunotherapy

Allergy Treatment Market, By Route of Administration:

  • Oral
  • Inhalers
  • Intranasal
  • Others

Allergy Treatment Market, By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Allergy Treatment Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Allergy Treatment Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Allergy Treatment Market

5. Voice of Customer

6. Global Allergy Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Eye Allergy, Food Allergy, Skin Allergy, Asthma, Rhinitis, Others)
    • 6.2.2. By Treatment (Anti-Allergy Medications v/s Immunotherapy)
    • 6.2.3. By Route of Administration (Oral, Inhalers, Intranasal, Others)
    • 6.2.4. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
    • 6.2.5. By Region
    • 6.2.6. By Company (2021)
  • 6.3. Market Map

7. North America Allergy Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Treatment
    • 7.2.3. By Route of Administration
    • 7.2.4. By Distribution Channel
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Allergy Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Treatment
        • 7.3.1.2.3. By Route of Administration
        • 7.3.1.2.4. By Distribution Channel
    • 7.3.2. Canada Allergy Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Treatment
        • 7.3.2.2.3. By Route of Administration
        • 7.3.2.2.4. By Distribution Channel
    • 7.3.3. Mexico Allergy Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Treatment
        • 7.3.3.2.3. By Route of Administration
        • 7.3.3.2.4. By Distribution Channel

8. Europe Allergy Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Treatment
    • 8.2.3. By Route of Administration
    • 8.2.4. By Distribution Channel
    • 8.2.5. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Allergy Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Treatment
        • 8.3.1.2.3. By Route of Administration
        • 8.3.1.2.4. By Distribution Channel
    • 8.3.2. Germany Allergy Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Treatment
        • 8.3.2.2.3. By Route of Administration
        • 8.3.2.2.4. By Distribution Channel
    • 8.3.3. United Kingdom Allergy Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Treatment
        • 8.3.3.2.3. By Route of Administration
        • 8.3.3.2.4. By Distribution Channel
    • 8.3.4. Italy Allergy Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Treatment
        • 8.3.4.2.3. By Route of Administration
        • 8.3.4.2.4. By Distribution Channel
    • 8.3.5. Spain Allergy Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Treatment
        • 8.3.5.2.3. By Route of Administration
        • 8.3.5.2.4. By Distribution Channel

9. Asia-Pacific Allergy Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Treatment
    • 9.2.3. By Route of Administration
    • 9.2.4. By Distribution Channel
    • 9.2.5. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Allergy Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Treatment
        • 9.3.1.2.3. By Route of Administration
        • 9.3.1.2.4. By Distribution Channel
    • 9.3.2. India Allergy Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Treatment
        • 9.3.2.2.3. By Route of Administration
        • 9.3.2.2.4. By Distribution Channel
    • 9.3.3. Japan Allergy Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Treatment
        • 9.3.3.2.3. By Route of Administration
        • 9.3.3.2.4. By Distribution Channel
    • 9.3.4. South Korea Allergy Treatment Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Treatment
        • 9.3.4.2.3. By Route of Administration
        • 9.3.4.2.4. By Distribution Channel
    • 9.3.5. Australia Allergy Treatment Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Type
        • 9.3.5.2.2. By Treatment
        • 9.3.5.2.3. By Route of Administration
        • 9.3.5.2.4. By Distribution Channel

10. South America Allergy Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Treatment
    • 10.2.3. By Route of Administration
    • 10.2.4. By Distribution Channel
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Allergy Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Treatment
        • 10.3.1.2.3. By Route of Administration
        • 10.3.1.2.4. By Distribution Channel
    • 10.3.2. Argentina Allergy Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Treatment
        • 10.3.2.2.3. By Route of Administration
        • 10.3.2.2.4. By Distribution Channel
    • 10.3.3. Colombia Allergy Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Treatment
        • 10.3.3.2.3. By Route of Administration
        • 10.3.3.2.4. By Distribution Channel

11. Middle East and Africa Allergy Treatment Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type
    • 11.2.2. By Treatment
    • 11.2.3. By Route of Administration
    • 11.2.4. By Distribution Channel
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Allergy Treatment Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Treatment
        • 11.3.1.2.3. By Route of Administration
        • 11.3.1.2.4. By Distribution Channel
    • 11.3.2. Saudi Arabia Allergy Treatment Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Treatment
        • 11.3.2.2.3. By Route of Administration
        • 11.3.2.2.4. By Distribution Channel
    • 11.3.3. UAE Allergy Treatment Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Treatment
        • 11.3.3.2.3. By Route of Administration
        • 11.3.3.2.4. By Distribution Channel

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Johnson & Johnson
  • 14.2. Sanofi SA
  • 14.3. GlaxoSmithKline plc.
  • 14.4. F. Hoffmann-La Roche AG
  • 14.5. Leti Pharma GmbH
  • 14.6. AbbVie Inc.
  • 14.7. Alembic Pharmaceuticals Limited
  • 14.8. Bausch Health Companies Inc.
  • 14.9. Novartis AG
  • 14.10. ALK-Abello AS

15. Strategic Recommendations